A Teesside manufacturer working in the medical research field is expanding thanks to funding from the Let’s Grow campaign, backed by the Journal.
Billingham-based Cambridge Research Biochemicals (CRB) is set to create more jobs after winning £65,000 from the £30m Regional Growth Fund programme. The boost will allow it to move from its current base at Belasis Park to a neighbouring Enterprise Zone site at Belasis Hall Technology Park, which is more than twice the size.
CRB, a specialist manufacturer of custom-made peptides and antibodies – both key tools in drug discovery – supplies some of the world’s largest pharmaceutical companies as well as leading research institutes.
The grant win was timely as the company, the world’s second-oldest peptide manufacturer, is in a flourishing market, growing at a rate of 15% per year.
Commercial director Emily Humphrys said: “The expansion will allow us to strengthen our team and operating base and gives us ample room to grow again in the future.
“We knew we needed to expand to take advantage of new markets and opportunities. The financial support from this grant and a five year Business Rate relief scheme has made the difference in ensuring that this project can go ahead sooner rather than later.”
The Let’s Grow grant will support the company’s £900,000 investment programme, including the purchase and refurbishment of a 10,000 sq ft base. CRB’s move also allows it to create more manufacturing space and fast-track growth from overseas.
Working with the Journal – and its sister title The Evening Gazette – on Let’s Grow is business improvement company BE Group and chartered accountancy practice UNW. The campaign provides grant support from £50,000 to £1m for capital investment and research and development projects, creating or safeguarding jobs in the North East.